Indefinite Delivery Contract HHSD200201141271I

Award Date 9/29/11
Last Date to Order 9/28/20
Federal Agency
CDC Pittsburgh
Ultimate Awardee
Not listed
Pricing Type
Cost No Fee
Legislative Mandate
Service Contract Act
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
The U.S. Centers for Disease Control and Prevention (CDC) awarded a multiple award indefinite delivery, indefinite quantity (IDIQ) contract known as the Tuberculosis Epidemiology Studies Consortium to conduct research aimed at improving the diagnosis and treatment of latent tuberculosis infection. Under this IDIQ, the CDC awarded a $5,099,064.36 delivery order contract to the Denver Health and Hospital Authority, a 555-bed academic health system, to perform a comparison study on tuberculosis...
The University of North Texas Health Science Center at Fort Worth (UNTHSC) was awarded a $81,989,926.61 indefinite delivery contract by the Federal Correctional Institution Fort Worth, a civilian agency, to provide comprehensive medical services for the incarcerated population. This includes inpatient, outpatient, specialty consultations, and dialysis care. The contract does not have a set-aside designation. Under this IDC, UNTHSC has received multiple firm fixed price delivery orders to deliver...
This indefinite delivery contract (IDC) was awarded to The University of Texas Southwestern Medical Center (UT Southwestern) by the Centers for Disease Control and Prevention (CDC) under the Safety and Healthcare Epidemiology Prevention Research Development 2016 (SHEPheRD 2016) IDIQ contract. The $200 million multiple-award IDC is intended to provide a broad range of functions and services in support of the CDC's public health initiatives. UT Southwestern, a non-profit academic medical center...
This indefinite delivery contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to The University of North Texas Health Science Center at Fort Worth (UNTHSC) as a single award with a $146,300,000 ceiling value and a period of performance through July 2031. The contract is for the provision of pre-clinical models of infectious diseases, including the development and refinement of small animal, non-human primate, and animal...
The University of Texas Medical Branch at Galveston (UTMB) holds a single award indefinite delivery contract (IDC) with the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services. The $67.4 million IDC, awarded on September 15, 2003, provides NIAID with a flexible contracting mechanism to efficiently order a range of preclinical research and development services from UTMB to support the evaluation of candidate...
The University of Texas Medical Branch at Galveston (UTMB) holds an Indefinite Delivery/Indefinite Quantity (IDIQ) contract under the Preclinical Services for HIV Therapeutics vehicle awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services' National Institutes of Health. Through this IDIQ, UTMB provides preclinical development support across various task areas, including in vitro testing, synthesis of therapeutic...
The Centers for Disease Control and Prevention awarded a multiple award indefinite delivery contract to The Trustees of Columbia University in the City of New York. The contract established a total potential value of $28 million for research and development services related to tuberculosis elimination and surveillance. Task orders issued to Columbia University under the contract include epidemiological studies on TB diagnosis and treatment outcomes among at-risk populations totaling...
The Indefinite Delivery Contract (IDC) awarded by the Centers for Disease Control and Prevention (CDC) to the Maryland Department of Health Vital Statistics Administration Division is part of the Tuberculosis Epidemiology Studies Consortium (TBESC) program. The contract, valued at $5,510,000, is for a study comparing tuberculosis testing methods in latent tuberculosis infection (LTBI) patients. A $4,178,577.57 delivery order has been issued under this IDC for a study comparing the Tuberculin...
This indefinite delivery contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to the University of Texas Medical Branch at Galveston (UTMB) to provide preclinical models and services for the development and evaluation of medical countermeasures against infectious diseases. The $146.3M single-award IDC has a 7-year ordering period and covers four task areas: (A) small animal...
The University of New Mexico Health Sciences Center (UNM HSC) has been awarded an Indefinite Delivery Contract (IDC) by the National Institute of Allergy and Infectious Diseases (NIAID) under the NIAID Animal Models of Infectious Diseases 2010-2017 program. This multiple-award contract has a ceiling value of $20,000,000 and a period of performance through March 2017. Under this IDC, UNM HSC has received two delivery orders to date. The first order, valued at $2,360,128.51, supports the...

The University of North Texas Health Science Center at Fort Worth (UNTHSC) holds an indefinite delivery contract (IDC) with the Centers for Disease Control and Prevention (CDC) to support the Tuberculosis Epidemiology Studies Consortium. Under this $5.51 million IDC, UNTHSC is conducting a comparative study on tuberculosis (TB) testing methods to evaluate the performance of the tuberculin skin test (TST) versus interferon gamma release assays (IGRAs) in diagnosing latent TB infection (LTBI) and predicting progression to active disease. This $3.75 million task order is being performed in collaboration with Tarrant County Public Health, which is providing access to its TB, refugee, and other clinics to facilitate UNTHSC's research activities. The IDC does not have a set-aside designation, leveraging UNTHSC's status as a U.S. state government entity and academic medical institution to deliver these services. The period of performance for this task order is from September 2011 to September 2021, supporting the CDC's broader efforts to improve the diagnosis and treatment of LTBI.

In addition to this task order, UNTHSC holds two other major IDCs that allow it to provide ongoing services to federal agencies. The first is a $146.3 million IDC with the National Institute of Allergy and Infectious Diseases to develop pre-clinical models of infectious diseases, while the second is a $79.1 million IDC with the Bureau of Prisons to deliver comprehensive healthcare services at the Federal Medical Center Carswell from 2022 to 2027. These IDCs enable UNTHSC to maintain long-term partnerships with federal agencies, applying its medical and research expertise to address their programmatic needs.

Generated 2/25/25, 10:11 AM